Gut hormone stimulation as a therapeutic approach in oral peptide delivery
Journal of Controlled Release · 2024
DOI: 10.1016/j.jconrel.2024.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Ana Beloqui. Beteiligte Einrichtung: UCLouvain, Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, 1200 Brussels, Belgium; WEL Re…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Gastrointestinal Hormones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this contribution to the Orations - New Horizons of the Journal of Controlled Release, I discuss the research that we have conducted on gut hormone stimulation as a therapeutic strategy in oral peptide delivery. One of the greatest challenges in oral drug delivery involves the development of new drug delivery systems that enable the absorption of therapeutic peptides into the systemic circulation at therapeutically relevant concentrations. This scenario is especially challenging in the treatment of chronic diseases (such as type 2 diabetes mellitus), wherein daily injections are often needed. However, for certain peptides, there may be an alternative in drug delivery to meet the need for increased peptide bioavailability; this is the case for gut hormone mimetics (including glucagon-like peptide (GLP)-1 or GLP-2). One plausible alternative for improved oral delivery of these peptides is the co-stimulation of the endogenous secretion of the hormone to reach therapeutic levels of the peptide. This oration will be focused on studies conducted on the stimulation of gut hormones secreted from enteroendocrine L cells in the treatment of gastrointestinal disorders, including a critical discussion of the limitations and future perspectives of implementing this approach in the clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UCLouvain, Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, 1200 Brussels, Belgium; WEL Research Institute, Avenue Pasteur, 6, 1300 Wavre, Belgium. Electronic a…
Zitieren
APA
Beloqui, A. (2024). Gut hormone stimulation as a therapeutic approach in oral peptide delivery. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.07.007
Vancouver
Beloqui A. Gut hormone stimulation as a therapeutic approach in oral peptide delivery. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.07.007
BibTeX
@article{Beloqui2024,
author = {Beloqui, Ana},
title = {Gut hormone stimulation as a therapeutic approach in oral peptide delivery},
journal = {Journal of Controlled Release},
year = {2024},
doi = {10.1016/j.jconrel.2024.07.007}
}
EUVIMED